Riley Antony A, CFO of Forte Biosciences ($FBRX), made one open market purchase of company shares in the last year, totaling about $255,000, with the most recent on December 30, 2025. This ranks 1,286th among 4,983 insiders in our database, where the average buy is $1.46 million across 3.29 transactions. No open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Common Stock | 375 | $0.00 | 42,116.0000 | 12,526,935 | 0.90% | 0.00% |
| April 1, 2026 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 375 | $0.00 | 1,125.0000 | 12,526,935 | 25.00% | 0.00% |
| April 1, 2026 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | F | Common Stock | 134 | $24.86 | 41,982.0000 | 12,526,935 | 0.32% | 0.00% |
| Jan. 12, 2026 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 12,526,935 | 9999.99% | 0.72% |
| Jan. 12, 2026 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 60000 | $0.00 | 60,000.0000 | 12,526,935 | 9999.99% | 0.48% |
| Dec. 30, 2025 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | P | Common Stock | 9680 | $26.33 | 41,520.0000 | 12,526,935 | 30.40% | 0.08% |
| Jan. 1, 2026 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 375 | $0.00 | 1,500.0000 | 12,526,935 | 20.00% | 0.00% |
| Jan. 1, 2026 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | F | Common Stock | 154 | $27.27 | 41,741.0000 | 12,526,935 | 0.37% | 0.00% |
| Jan. 1, 2026 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Common Stock | 375 | $0.00 | 41,895.0000 | 12,526,935 | 0.90% | 0.00% |
| Oct. 1, 2025 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Common Stock | 375 | $0.00 | 31,974.0000 | 6,581,667 | 1.19% | 0.01% |
| Oct. 1, 2025 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | F | Common Stock | 134 | $14.52 | 31,840.0000 | 6,581,667 | 0.42% | 0.00% |
| Oct. 1, 2025 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 375 | $0.00 | 1,875.0000 | 6,581,667 | 16.67% | 0.01% |
| July 1, 2025 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Common Stock | 375 | $0.00 | 31,733.0000 | 6,581,667 | 1.20% | 0.01% |
| July 1, 2025 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | F | Common Stock | 134 | $12.44 | 31,599.0000 | 6,581,667 | 0.42% | 0.00% |
| July 1, 2025 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 375 | $0.00 | 2,250.0000 | 6,581,667 | 14.29% | 0.01% |
| April 1, 2025 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Common Stock | 375 | $0.00 | 31,372.0000 | 6,581,667 | 1.21% | 0.01% |
| April 1, 2025 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | F | Common Stock | 154 | $7.43 | 31,218.0000 | 6,581,667 | 0.49% | 0.00% |
| April 1, 2025 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 375 | $0.00 | 2,625.0000 | 6,581,667 | 12.50% | 0.01% |
| March 20, 2025 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 323000 | $0.00 | 323,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2025 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 375 | $0.00 | 3,000.0000 | 0 | 11.11% | 0.00% |
| Jan. 1, 2025 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Common Stock | 375 | $0.00 | 31,151.0000 | 0 | 1.22% | 0.00% |
| Jan. 1, 2025 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | F | Common Stock | 154 | $22.71 | 30,997.0000 | 0 | 0.49% | 0.00% |
| Nov. 21, 2024 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | P | Common Stock | 22514 | $5.55 | 30,776.0000 | 0 | 272.50% | 0.00% |
| Oct. 1, 2024 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 375 | $0.00 | 3,375.0000 | 0 | 10.00% | 0.00% |
| Oct. 1, 2024 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | F | Common Stock | 133 | $5.16 | 8,262.0000 | 0 | 1.58% | 0.00% |
| Oct. 1, 2024 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Common Stock | 375 | $0.00 | 8,395.0000 | 0 | 4.68% | 0.00% |
| July 1, 2024 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Common Stock | 9375 | $0.00 | 203,849.0000 | 0 | 4.82% | 0.00% |
| July 1, 2024 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 9375 | $0.00 | 93,750.0000 | 0 | 9.09% | 0.00% |
| July 1, 2024 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | F | Common Stock | 3345 | $0.55 | 200,504.0000 | 0 | 1.64% | 0.00% |
| April 1, 2024 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Common Stock | 9375 | $0.00 | 197,819.0000 | 0 | 4.97% | 0.00% |
| April 1, 2024 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 9375 | $0.00 | 103,125.0000 | 0 | 8.33% | 0.00% |
| April 1, 2024 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | F | Common Stock | 3345 | $0.71 | 194,474.0000 | 0 | 1.69% | 0.00% |
| March 21, 2024 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 350000 | $0.00 | 350,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2024 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | Chief Financial Officer | F | Common Stock | 3841 | $0.82 | 188,444.0000 | 0 | 2.00% | 0.00% |
| Jan. 1, 2024 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | Chief Financial Officer | M | Restricted Stock Units | 9375 | $0.00 | 112,500.0000 | 0 | 7.69% | 0.00% |
| Jan. 1, 2024 | Forte Biosciences, Inc. | $FBRX | Riley Antony A | Chief Financial Officer | M | Common Stock | 9375 | $0.00 | 192,285.0000 | 0 | 5.13% | 0.00% |